Clinical, Functional, Immunological and Genetic Factors on the Severity of the Course of Coronavirus Infection

NCT04987853 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-08-03

No results posted yet for this study

Summary

The purpose of the program. To determine the clinical, functional, immunological, and genetic factors affecting the severity of the course of acute coronavirus infection COVID-19 and PostCovid syndrome, in order to develop management tactics for such patients to reduce the risk of complications and disability.

Conditions

  • Covid19
  • Corona Virus Infection

Interventions

DIAGNOSTIC_TEST

Clinical and functional analysis

General blood analysis - Complete blood count on an analyzer with differentiation of 5 classes of cells, the ratio of neutrophils to lymphocytes; Blood chemistry - ALT, AST, total bilirubin, direct, LDH, CRP, alpha-amylase, creatinine, urea, glucose, ferritin, glycosylated hemoglobin, vitamin 25 - OH vitamin D, vitamin B12; Coagulogram - D-dimers, fibrinogen, INR, APTT; Other - NT-pro BNP, Homocysteine, IL 6, Troponin, blood group determination; Linked immunosorbent assay - Determination of IgG and IgM antibodies to SARS-CoV-2 coronavirus (COVID-19) in blood serum, RBD; Functional diagnostics • ECG * EchoCG + strain * CT scan of the lungs * Holter * SMAD * Kidney ultrasound * Ultrasound * Doppler ultrasonography of veins and arteries * Chalder Scale, EQ Questionnaire

DIAGNOSTIC_TEST

Neurological analysis

Neurological examination with the isolation of neurological syndromes (motor, cognitive impairments, sleep disorders, asthenic-depressive syndromes, etc.). 2\. Neuropsychological methods - research on the scales of anxiety and depression, MMSE, etc. 3\. Instrumental method - EEG, polysonography, ultrasound of the neck vessels, CT perfusion. 4\. Laboratory research methods: 1. The study of antibodies to some neurospecific antigens - myelin basic protein (MBP), neurospecific enolase (NSE). 2. Study of cellular immunity (CD3 +, CD4 +, CD8 +) and general indicators of humoral immunity (IgG, IgA, IgM, circulating immune complexes).

DIAGNOSTIC_TEST

Immunological analysis:

A comprehensive immunological analysis will be carried out to determine the level of the immune response. Calculation of the level of CD4 +, CD8 + and NK cells. The level of antibodies of the IgG and IgM classes to the proteins of the coronavirus S1, RBD and N was determined

DIAGNOSTIC_TEST

Genetic analysis:

Isolation (extraction) of DNA will be performed from whole blood using commercial kits according to the manufacturer's instructions. To analyze a large number of genetic markers, it is planned to carry out genome-wide sequencing followed by analysis of genetic polymorphisms of candidate genes encoding coronavirus receptors and immunological factors.

Sponsors & Collaborators

  • Nazarbayev University Medical Center

    collaborator OTHER
  • National Research Center for Cardiac Surgery, Kazakhstan

    lead OTHER

Principal Investigators

  • Makhabbat Sansyzbaeva · Chairman of the Board of "National Research Cardiac Surgery Centre" JSC

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2022-12-01
Completion
2023-06-01

Countries

  • Kazakhstan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04987853 on ClinicalTrials.gov